Free Trial

Acrivon Therapeutics (ACRV) Short Interest Ratio & Short Volume

-0.34 (-3.82%)
(As of 05/20/2024 ET)

Acrivon Therapeutics Short Interest Data

Current Short Interest
Previous Short Interest
Change Vs. Previous Month
Dollar Volume Sold Short
$9.82 million
Short Interest Ratio
1.4 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
Float Size
Short Percent of Float
Today's Trading Volume
Average Trading Volume
Today's Volume Vs. Average
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Acrivon Therapeutics ?

Sign up to receive the latest short interest report for Acrivon Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ACRV Short Interest Over Time

ACRV Days to Cover Over Time

ACRV Percentage of Float Shorted Over Time

Acrivon Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20241,080,000 shares $9.82 million +4.9%5.2%1.4 $9.09
4/15/20241,030,000 shares $9.90 million +93.3%5.0%1.4 $9.61
3/31/2024533,000 shares $3.81 million +10.1%4.4%0.8 $7.15
3/15/2024484,000 shares $3.00 million +22.7%4.0%6.7 $6.19
2/29/2024394,600 shares $1.92 million +5.9%3.3%6.2 $4.86
2/15/2024372,700 shares $1.49 million +13.6%3.1%6.7 $4.00
1/31/2024328,000 shares $1.20 million No Change2.8%7.5 $3.65
1/15/2024328,000 shares $1.57 million +3.6%2.8%8.9 $4.79
12/31/2023316,700 shares $1.56 million +7.9%2.7%9.3 $4.92
12/15/2023293,500 shares $1.35 million +3.6%2.5%10.6 $4.59
11/30/2023283,400 shares $1.15 million -2.3%2.4%12.3 $4.05
11/15/2023290,200 shares $1.51 million -5.7%2.5%15.1 $5.19
10/31/2023307,600 shares $1.61 million +0.9%2.7%18.6 $5.24
10/15/2023304,900 shares $1.85 million -4.1%2.7%21.6 $6.06
9/30/2023317,800 shares $3.04 million -1.5%2.8%22.9 $9.56
9/15/2023322,600 shares $3.40 million 0.0%2.8%24.6 $10.55
8/31/2023322,700 shares $3.78 million -2.8%2.8%15 $11.72
8/15/2023332,100 shares $3.89 million -1.2%2.5%14.3 $11.72
7/31/2023336,000 shares $4.18 million -3.0%2.5%12.8 $12.44
7/15/2023346,300 shares $4.30 million -4.5%2.6%12.4 $12.41
6/30/2023362,600 shares $4.70 million +0.7%2.7%11.9 $12.96
6/15/2023360,000 shares $4.30 million -5.5%2.7%10.6 $11.95
5/31/2023380,900 shares $4.49 million -6.3%2.9%5.6 $11.78
5/15/2023406,600 shares $5.73 million No Change2.8%5.4 $14.09

ACRV Short Interest - Frequently Asked Questions

What is Acrivon Therapeutics' current short interest?

Short interest is the volume of Acrivon Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,080,000 shares of ACRV short. 5.22% of Acrivon Therapeutics' shares are currently sold short. Learn More on Acrivon Therapeutics' current short interest.

What is a good short interest ratio for Acrivon Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACRV shares currently have a short interest ratio of 1.0. Learn More on Acrivon Therapeutics's short interest ratio.

What is a good short interest percentage for Acrivon Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.22% of Acrivon Therapeutics' floating shares are currently sold short.

Is Acrivon Therapeutics' short interest increasing or decreasing?

Acrivon Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 1,080,000 shares, an increase of 4.9% from the previous total of 1,030,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Acrivon Therapeutics' float size?

Acrivon Therapeutics currently has issued a total of 22,640,000 shares. Some of Acrivon Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acrivon Therapeutics currently has a public float of 20,700,000 shares.

How does Acrivon Therapeutics' short interest compare to its competitors?

5.22% of Acrivon Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Acrivon Therapeutics: Organigram Holdings Inc. (5.87%), Inventiva S.A. (0.13%), Atossa Therapeutics, Inc. (9.10%), Lifecore Biomedical, Inc. (6.60%), Incannex Healthcare Inc. (0.48%), Zevra Therapeutics, Inc. (6.15%), Galectin Therapeutics Inc. (7.35%), Greenwich LifeSciences, Inc. (3.24%), Trevi Therapeutics, Inc. (1.49%), Alimera Sciences, Inc. (0.23%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Acrivon Therapeutics stock?

Short selling ACRV is an investing strategy that aims to generate trading profit from Acrivon Therapeutics as its price is falling. ACRV shares are trading down $0.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Acrivon Therapeutics?

A short squeeze for Acrivon Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACRV, which in turn drives the price of the stock up even further.

How often is Acrivon Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACRV, twice per month. The most recent reporting period available is April, 30 2024.

More Short Interest Resources from MarketBeat

This page (NASDAQ:ACRV) was last updated on 5/21/2024 by Staff

From Our Partners